» Authors » Elena Pettini

Elena Pettini

Explore the profile of Elena Pettini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 483
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ciabattini A, Pettini E, Fiorino F, Polvere J, Lucchesi S, Coppola C, et al.
EBioMedicine . 2025 Feb; 113:105577. PMID: 39908650
Background: Individuals with primary and secondary immunodeficiencies, being more susceptible to infections, are a priority for vaccination. Here, we determined and compared in a longitudinal study the immune response elicited...
2.
Pettini E, Ciabattini A, Fiorino F, Polvere J, Pastore G, Tozzi M, et al.
Vaccines (Basel) . 2024 Apr; 12(4). PMID: 38675750
Preventing SARS-CoV-2 infection is of utmost importance in allogeneic hematopoietic cell transplantation patients (allo-HCT), given their heightened susceptibility to adverse outcomes associated with SARS-CoV-2 infection. However, limited data are available...
3.
Kim J, Tack B, Fiorino F, Pettini E, Marchello C, Jacobs J, et al.
BMJ Open . 2024 Mar; 14(3):e080501. PMID: 38485477
Background: Invasive non-typhoidal (iNTS) disease is a significant health concern in sub-Saharan Africa. While our knowledge of a larger-scale variation is growing, understanding of the subnational variation in iNTS disease...
4.
Waerlop G, Leroux-Roels G, Pagnon A, Begue S, Salaun B, Janssens M, et al.
J Immunol Methods . 2023 Nov; 523:113584. PMID: 37918618
The magnitude and quality of cell-mediated immune responses elicited by natural infection or vaccination are commonly measured by Interferon-ɣ (IFN-ɣ) Enzyme-Linked ImmunoSpot (ELISpot) and Intracellular Cytokine Staining (ICS). To date,...
5.
Ciabattini A, Pastore G, Lucchesi S, Montesi G, Costagli S, Polvere J, et al.
Cells . 2023 Jul; 12(13). PMID: 37443740
The mRNA vaccines for SARS-CoV-2 have demonstrated efficacy and immunogenicity in the real-world setting. However, most of the research on vaccine immunogenicity has been centered on characterizing the antibody response,...
6.
Polvere J, Fabbiani M, Pastore G, Rancan I, Rossetti B, Durante M, et al.
Commun Med (Lond) . 2023 Jan; 3(1):13. PMID: 36717688
Background: Limited longitudinal data are available on immune response to mRNA SARS-CoV-2 vaccination in people living with HIV (PLWHIV); therefore, new evidence on induction and persistence of spike-specific antibodies and...
7.
Pettini E, Medaglini D, Ciabattini A
Front Immunol . 2022 Dec; 13:1058748. PMID: 36505416
B cells play a fundamental role in host defenses against viral infections. Profiling the B cell response elicited by SARS-CoV-2 vaccination, including the generation and persistence of antigen-specific memory B...
8.
Begue S, Waerlop G, Salaun B, Janssens M, Bellamy D, Cox R, et al.
Front Immunol . 2022 Nov; 13:982887. PMID: 36341380
Despite the knowledge that cell-mediated immunity (CMI) contributes to the reduction of severe influenza infection, transmission, and disease outcome, the correlates of protection for cell-mediated immunity remain still unclear. Therefore,...
9.
Waerlop G, Leroux-Roels G, Lambe T, Bellamy D, Medaglini D, Pettini E, et al.
Front Immunol . 2022 Sep; 13:984642. PMID: 36159843
Influenza continues to be the most important cause of viral respiratory disease, despite the availability of vaccines. Today's evaluation of influenza vaccines mainly focuses on the quantitative and functional analyses...
10.
Franco Moscardini I, Santoro F, Carraro M, Gerlini A, Fiorino F, Germoni C, et al.
Front Cell Infect Microbiol . 2022 Jul; 12:869763. PMID: 35795182
The stimulation of immune system cells with live or killed bacteria is essential for understanding the host response to pathogens. In the present study, we propose a model combining transcriptomic...